TY - JOUR
T1 - Increased Chamber Resting Tone Is a Key Determinant of Left Ventricular Diastolic Dysfunction
AU - Tamargo, María
AU - Martínez-Legazpi, Pablo
AU - Espinosa, M. Ángeles
AU - Lyon, Aurore
AU - Méndez, Irene
AU - Gutiérrez-Ibañes, Enrique
AU - Fernández, Ana I.
AU - Prieto-Arévalo, Raquel
AU - González-Mansilla, Ana
AU - Arts, Theo
AU - Delhaas, Tammo
AU - Mombiela, Teresa
AU - Sanz-Ruiz, Ricardo
AU - Elízaga, Jaime
AU - Yotti, Raquel
AU - Tschöpe, Carsten
AU - Fernández-Avilés, Francisco
AU - Lumens, Joost
AU - Bermejo, Javier
N1 - Funding Information:
This study was supported by grant PI15/02229 from the Instituto de Salud Carlos III, Spain. Dr Tamargo was partially supported by grants from the Fundación para la Investigación Biomédica Gregorio Marañón, Spain, and CM20/00054 from the Instituto de Salud Carlos III, Spain. The latter and CIBERCV are co-financed by the European Development Regional Fund “A Way to Achieve Europe” (EDRF). In addition, the work was supported by the Netherlands Organization for Scientific Research (NWO-ZonMw, VIDI grant 016.176.340 to Dr Lumens).
Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/12/1
Y1 - 2023/12/1
N2 - BACKGROUND: Twitch-independent tension has been demonstrated in cardiomyocytes, but its role in heart failure (HF) is unclear. We aimed to address twitch-independent tension as a source of diastolic dysfunction by isolating the effects of chamber resting tone (RT) from impaired relaxation and stiffness. METHODS: We invasively monitored pressure-volume data during cardiopulmonary exercise in 20 patients with hypertrophic cardiomyopathy, 17 control subjects, and 35 patients with HF with preserved ejection fraction. To measure RT, we developed a new method to fit continuous pressure-volume measurements, and first validated it in a computational model of loss of cMyBP-C (myosin binding protein-C). RESULTS: In hypertrophic cardiomyopathy, RT (estimated marginal mean [95% CI]) was 3.4 (0.4-6.4) mm Hg, increasing to 18.5 (15.5-21.5) mm Hg with exercise (P<0.001). At peak exercise, RT was responsible for 64% (53%-76%) of end-diastolic pressure, whereas incomplete relaxation and stiffness accounted for the rest. RT correlated with the levels of NT-proBNP (N-terminal pro-B-type natriuretic peptide; R=0.57; P=0.02) and with pulmonary wedge pressure but following different slopes at rest and during exercise (R2=0.49; P<0.001). In controls, RT was 0.0 mm Hg and 1.2 (0.3-2.8) mm Hg in HF with preserved ejection fraction patients and was also exacerbated by exercise. In silico, RT increased in parallel to the loss of cMyBP-C function and correlated with twitch-independent myofilament tension (R=0.997). CONCLUSIONS: Augmented RT is the major cause of LV diastolic chamber dysfunction in hypertrophic cardiomyopathy and HF with preserved ejection fraction. RT transients determine diastolic pressures, pulmonary pressures, and functional capacity to a greater extent than relaxation and stiffness abnormalities. These findings support antimyosin agents for treating HF.
AB - BACKGROUND: Twitch-independent tension has been demonstrated in cardiomyocytes, but its role in heart failure (HF) is unclear. We aimed to address twitch-independent tension as a source of diastolic dysfunction by isolating the effects of chamber resting tone (RT) from impaired relaxation and stiffness. METHODS: We invasively monitored pressure-volume data during cardiopulmonary exercise in 20 patients with hypertrophic cardiomyopathy, 17 control subjects, and 35 patients with HF with preserved ejection fraction. To measure RT, we developed a new method to fit continuous pressure-volume measurements, and first validated it in a computational model of loss of cMyBP-C (myosin binding protein-C). RESULTS: In hypertrophic cardiomyopathy, RT (estimated marginal mean [95% CI]) was 3.4 (0.4-6.4) mm Hg, increasing to 18.5 (15.5-21.5) mm Hg with exercise (P<0.001). At peak exercise, RT was responsible for 64% (53%-76%) of end-diastolic pressure, whereas incomplete relaxation and stiffness accounted for the rest. RT correlated with the levels of NT-proBNP (N-terminal pro-B-type natriuretic peptide; R=0.57; P=0.02) and with pulmonary wedge pressure but following different slopes at rest and during exercise (R2=0.49; P<0.001). In controls, RT was 0.0 mm Hg and 1.2 (0.3-2.8) mm Hg in HF with preserved ejection fraction patients and was also exacerbated by exercise. In silico, RT increased in parallel to the loss of cMyBP-C function and correlated with twitch-independent myofilament tension (R=0.997). CONCLUSIONS: Augmented RT is the major cause of LV diastolic chamber dysfunction in hypertrophic cardiomyopathy and HF with preserved ejection fraction. RT transients determine diastolic pressures, pulmonary pressures, and functional capacity to a greater extent than relaxation and stiffness abnormalities. These findings support antimyosin agents for treating HF.
KW - cardiomyocytes
KW - cardiomyopathy, hypertrophic
KW - heart failure
KW - LV diastolic dysfunction
U2 - 10.1161/CIRCHEARTFAILURE.123.010673
DO - 10.1161/CIRCHEARTFAILURE.123.010673
M3 - Article
SN - 1941-3289
VL - 16
SP - E010673
JO - Circulation-Heart Failure
JF - Circulation-Heart Failure
IS - 12
M1 - 010673
ER -